Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Piao, Jinxiang | - |
dc.contributor.author | Yoo, Chaeyoung | - |
dc.contributor.author | Kim, SeonYoung | - |
dc.contributor.author | Whang, Youn-Wha | - |
dc.contributor.author | Choi, Cheol Ung | - |
dc.contributor.author | Shin, Sehyun | - |
dc.date.accessioned | 2022-03-15T08:41:35Z | - |
dc.date.available | 2022-03-15T08:41:35Z | - |
dc.date.created | 2022-03-14 | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1386-0291 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/139046 | - |
dc.description.abstract | BACKGROUND: Assessment of platelet inhibition for aspirin therapy is important to manage patients who are at potential risk of developing thrombotic and hemorrhagic complications. OBJECTIVE: This study aimed to evaluate a new platelet assay (Anysis-aspirin), compare it with VerifyNow-aspirin in patients with cardiac diseases, and analyze the aspirin resistance rates between the two devices. METHODS: Citrated blood samples were collected from patients with cardiac diseases referred for the aspirin response test. In the Anysis assay, a test result was provided with a blood flow migration distance (MD) until blood flow stoppage, which was comparable to aspirin reaction units (ARUs) obtained using VerifyNow. The measurements were simultaneously conducted using the two devices and compared. RESULTS: The MD without and with aspirin use was 160 +/- 33 and 254 +/- 23 mm, respectively (p < 0.0001). Compared with VerifyNow (reference), the sensitivity and specificity of Anysis-200 were 96.3 and 90.3%, respectively (area under the curve, 0.968). Furthermore, the aspirin resistance rate in aspirin-administered patients was 20.9% using VerifyNow and 16.5% for Anysis-200. The Cohen's kappa coefficient between the two devices was 0.81, indicating an almost perfect agreement between the two devices. CONCLUSIONS: Anysis-aspirin, a novel aspirin assay for assessing platelet inhibition, showed excellent agreement with VerifyNow-aspirin with high accuracy and precision. The Anysis-aspirin assay would be used as a point-of-care test to assess aspirin non-responsiveness and abnormal platelet reactivity. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IOS PRESS | - |
dc.subject | RESISTANCE | - |
dc.subject | MECHANISMS | - |
dc.subject | REACTIVITY | - |
dc.title | Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, Sehyun | - |
dc.identifier.doi | 10.3233/CH-211171 | - |
dc.identifier.scopusid | 2-s2.0-85119419900 | - |
dc.identifier.wosid | 000719843100007 | - |
dc.identifier.bibliographicCitation | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, v.79, no.2, pp.327 - 334 | - |
dc.relation.isPartOf | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | - |
dc.citation.title | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | - |
dc.citation.volume | 79 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 327 | - |
dc.citation.endPage | 334 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | REACTIVITY | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordAuthor | Anysis-200 analyzer | - |
dc.subject.keywordAuthor | Platelet function | - |
dc.subject.keywordAuthor | VerifyNow | - |
dc.subject.keywordAuthor | aspirin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.